UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

Pathological lesions in colonic biopsies during Parkinson’s disease

Gut, 2008-12, Vol.57 (12), p.1741-1743

2008

Volltextzugriff (PDF)

High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study

European journal of neurology, 2018-01, Vol.25 (1), p.120-127

2018

Volltextzugriff (PDF)

Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy

Neurological sciences, 2020-07, Vol.41 (7), p.1931-1933

2020

Volltextzugriff (PDF)

Distribution of grey matter atrophy in Huntington’s disease patients: A combined ROI-based and voxel-based morphometric study

NeuroImage (Orlando, Fla.), 2006-10, Vol.32 (4), p.1562-1575

2006

Volltextzugriff (PDF)

Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more

Revue neurologique, 2021-03, Vol.177 (3), p.260-271

2021

Volltextzugriff (PDF)

French guidelines for the diagnosis and management of Tourette syndrome

Revue neurologique, 2024-05

2024

Volltextzugriff (PDF)

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

Brain (London, England : 1878), 1999-08, Vol.122 (8), p.1437-1448

1999

Volltextzugriff (PDF)

Tourette’s syndrome and deep brain stimulation

Journal of neurology, neurosurgery and psychiatry, 2005-07, Vol.76 (7), p.992-995

2005

Volltextzugriff (PDF)

STW5 (Iberogast®) for constipation in Parkinson's disease

Revue neurologique, 2021-03, Vol.177 (3), p.296-301

2021

Volltextzugriff (PDF)

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort

European journal of neurology, 2012-01, Vol.19 (1), p.28-37

2012

Volltextzugriff (PDF)

How do Parkinson's disease patients manage Ramadan fasting? An observational study

Revue neurologique, 2019-10, Vol.175 (9), p.560-563

2019

Volltextzugriff (PDF)

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

Brain (London, England : 1878), 1999-08, Vol.122 ( Pt 8), p.1421-1436

1999

Volltextzugriff (PDF)

Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

Annals of neurology, 1998-09, Vol.44 (S1), p.S115-S120

1998

Volltextzugriff (PDF)

Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation

Journal of medical genetics, 2009-12, Vol.46 (12), p.818-824

2009

Volltextzugriff (PDF)

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease

Neurology, 2000-08, Vol.55 (3), p.411

2000

Volltextzugriff (PDF)

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis

Neurology, 2000-07, Vol.55 (2), p.281

2000

Volltextzugriff (PDF)

Bilateral subthalamotomy through dbs electrodes: A rescue option for device-related infection

Neurology, 2009-10, Vol.73 (15), p.1243

2009

Volltextzugriff (PDF)

Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations

Neurology, 2008-03, Vol.70 (13), p.1010

2008

Volltextzugriff (PDF)

Decreased level of consciousness due to a depleted deep brain stimulator battery: Paving the way to wake up the brain?

Revue neurologique, 2019-04, Vol.175 (4), p.274-275

2019

Volltextzugriff (PDF)

Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method

Journal of neurosurgery, 2003-07, Vol.99 (1), p.89

2003

Volltextzugriff (PDF)

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients

Annals of neurology, 1999-08, Vol.46 (2), p.217-223

1999

Volltextzugriff (PDF)

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation

Journal of neurology, neurosurgery and psychiatry, 2000-05, Vol.68 (5), p.595-600

2000

Volltextzugriff (PDF)

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease

Journal of medical genetics, 2009-07, Vol.46 (7), p.458-464

2009

Volltextzugriff (PDF)

Bumetanide to treat Parkinson's disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and STN DBS: An open-label pilot study (BUMFOG)

Journal of the neurological sciences, 2019-10, Vol.405, p.207-207

2019

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(147)
Science & Technology
(146)
Life Sciences & Biomedicine
(144)
Neurosciences & Neurology
(101)
Male
(90)
Clinical Neurology
(84)
Female
(82)
Biological And Medical Sciences
(77)
Medical Sciences
(72)
Middle Aged
(71)
Neurology
(69)
Aged
(65)
Adult
(51)
Parkinson's Disease
(49)
Neurosciences
(44)
Life Sciences
(37)
Parkinson Disease - Physiopathology
(34)
Parkinson Disease - Drug Therapy
(26)
Aged, 80 And Over
(24)
Parkinson Disease - Therapy
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathological lesions in colonic biopsies during Parkinson’s disease

High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study

Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy

Distribution of grey matter atrophy in Huntington’s disease patients: A combined ROI-based and voxel-based morphometric study

L‐DOPA‐induced dyskinesias, motor fluctuations and health‐related quality of life: the COPARK survey

Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more

French guidelines for the diagnosis and management of Tourette syndrome

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

Tourette’s syndrome and deep brain stimulation

STW5 (Iberogast®) for constipation in Parkinson's disease

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort

How do Parkinson's disease patients manage Ramadan fasting? An observational study

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis

Bilateral subthalamotomy through dbs electrodes: A rescue option for device-related infection

Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations

Decreased level of consciousness due to a depleted deep brain stimulator battery: Paving the way to wake up the brain?

Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease

Bumetanide to treat Parkinson's disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and STN DBS: An open-label pilot study (BUMFOG)

Suchergebnisse filtern